Legend Biotech Corp - ADR

NASDAQ:LEGN  
33.11
-0.72 (-2.13%)
7:33:43 PM EDT: $33.12 +0.01 (+0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)5.98B
Current PEN/A
Forward PE N/A
2yr Forward PE 50.94
See more stats
Estimates Current Quarter
Revenue$279.46 Million
Adjusted EPS-$0.04
See more estimates
10-Day MA$34.34
50-Day MA$37.75
200-Day MA$35.49
See more pivots

Legend Biotech Corp - ADR Stock, NASDAQ:LEGN

2101 Cottontail Lane, Somerset, New Jersey 08873
United States of America
Phone: +1.737.317.5050
Number of Employees: 2609

Description

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.